Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by Macaque NK cells

Journal of Immunology

Volumn 189, Issue 9, 2012, Pages 4338-4348

  Maloveste, Sebastien M ^a   Chen, Dan ^a   Gostick, Emma ^b   Vivian, Julian P ^c   Plishka, Ronald J ^a   Iyengar, Ranjini ^a   Kruthers, Robin L ^a   Buckler White, Alicia ^a   Brooks, Andrew G ^d   Rossjohn, Jamie ^c   Price, David A ^a   Lafont, Bernard A P ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; DEGRANULATION; EX VIVO STUDY; MACACA NEMESTRINA; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; CELLS, CULTURED; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MACACA NEMESTRINA; PROTEIN BINDING; RECEPTORS, KIR3DL1;

EID: 84867908749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201360     Document Type: Article

References (56)

1. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49. (Pubitemid 33741974)
2. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
3. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268. (Pubitemid 351432802)
4. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
5. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502. (Pubitemid 351560518)
6. Raulet, D. H., and R. E. Vance. 2006. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6: 520-531. (Pubitemid 43980524)
7. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510. (Pubitemid 351560519)
8. Trowsdale, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15: 363-374. (Pubitemid 32907384)
9. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214. (Pubitemid 40364822)
10. Long, E. O. 2008. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 224: 70-84.
11. Hansasuta, P., T. Dong, H. Thananchai, M. Weekes, C. Willberg, H. Aldemir, S. Rowland-Jones, and V. M. Braud. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34: 1673-1679. (Pubitemid 39256049)
12. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874. (Pubitemid 39038423)
13. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434. (Pubitemid 35154456)
14. Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39: 733-740. (Pubitemid 46848586)
15. Alter, G., S. Rihn, K. Walter, A. Nolting, M. Martin, E. S. Rosenberg, J. S. Miller, M. Carrington, and M. Altfeld. 2009. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83: 6798-6805.
16. Letvin, N. L., M. D. Daniel, P. K. Sehgal, R. C. Desrosiers, R. D. Hunt, L. M. Waldron, J. J. MacKey, D. K. Schmidt, L. V. Chalifoux, and N. W. King. 1985. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230: 71-73. (Pubitemid 16221618)
17. Boyson, J. E., C. Shufflebotham, L. F. Cadavid, J. A. Urvater, L. A. Knapp, A. L. Hughes, and D. I. Watkins. 1996. The MHC class I genes of the rhesus monkey: different evolutionary histories of MHC class I and II genes in primates. J. Immunol. 156: 4656-4665. (Pubitemid 26174447)
18. Otting, N., C. M. Heijmans, R. C. Noort, N. G. de Groot, G. G. Doxiadis, J. J. van Rood, D. I. Watkins, and R. E. Bontrop. 2005. Unparalleled complexity of the MHC class I region in rhesus macaques. Proc. Natl. Acad. Sci. USA 102: 1626-1631. (Pubitemid 40209218)
19. Lafont, B. A., A. Buckler-White, R. Plishka, C. Buckler, and M. A. Martin. 2003. Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques. J. Immunol. 171: 875-885. (Pubitemid 36871400)
20. Smith, M. Z., C. J. Dale, R. De Rose, I. Stratov, C. S. Fernandez, A. G. Brooks, J. Weinfurter, K. Krebs, C. Riek, D. I. Watkins, et al. 2005. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 79: 684-695. (Pubitemid 40053851)
21. Krebs, K. C., Z. Jin, R. Rudersdorf, A. L. Hughes, and D. H. O'Connor. 2005. Unusually high frequency MHC class I alleles in Mauritian origin cynomolgus macaques. J. Immunol. 175: 5230-5239. (Pubitemid 41456408)
22. Evans, D. T., P. Jing, T. M. Allen, D. H. O'Connor, H. Horton, J. E. Venham, M. Piekarczyk, J. Dzuris, M. Dykhuzen, J. Mitchen, et al. 2000. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J. Virol. 74: 7400-7410. (Pubitemid 30613085)
23. Pal, R., D. Venzon, N. L. Letvin, S. Santra, D. C. Montefiori, N. R. Miller, E. Tryniszewska, M. G. Lewis, T. C. VanCott, V. Hirsch, et al. 2002. ALVAC-SIV- gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J. Virol. 76: 292-302. (Pubitemid 33139014)
24. Loffredo, J. T., J. Maxwell, Y. Qi, C. E. Glidden, G. J. Borchardt, T. Soma, A. T. Bean, D. R. Beal, N. A. Wilson, W. M. Rehrauer, et al. 2007. Mamu-B*08- positive macaques control simian immunodeficiency virus replication. J. Virol. 81: 8827-8832. (Pubitemid 47242856)
25. Fernandez, C. S., I. Stratov, R. De Rose, K. Walsh, C. J. Dale, M. Z. Smith, M. B. Agy, S. L. Hu, K. Krebs, D. I. Watkins, et al. 2005. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79: 5721-5731. (Pubitemid 40548241)
26. Choi, E. I., K. A. Reimann, and N. L. Letvin. 2008. In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J. Virol. 82: 6758-6761. (Pubitemid 351875151)
27. Hershberger, K. L., R. Shyam, A. Miura, and N. L. Letvin. 2001. Diversity of the killer cell Ig-like receptors of rhesus monkeys. J. Immunol. 166: 4380-4390. (Pubitemid 32233720)
28. Bimber, B. N., A. J. Moreland, R. W. Wiseman, A. L. Hughes, and D. H. O'Connor. 2008. Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J. Immunol. 181: 6301-6308.
29. Kruse, P. H., C. Rosner, and L. Walter. 2010. Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics 62: 281-293.
30. Blokhuis, J. H., M. K. van der Wiel, G. G. Doxiadis, and R. E. Bontrop. 2010. The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics 62: 295-306.
31. Bostik, P., J. Kobkitjaroen, W. Tang, F. Villinger, L. E. Pereira, D. M. Little, S. T. Stephenson, M. Bouzyk, and A. A. Ansari. 2009. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J. Immunol. 182: 3638-3649.
32. Chaichompoo, P., P. Bostik, S. Stephenson, S. Udompunturuk, J. Kobkitjaroen, K. Pattanapanyasat, and A. A. Ansari. 2010. Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques. Cell. Immunol. 263: 176-187.
33. Rosner, C., P. H. Kruse, M. Hermes, N. Otto, and L. Walter. 2011. Rhesus macaque inhibitory and activating KIR3D interact with Mamu-A-encoded ligands. J. Immunol. 186: 2156-2163.
34. Colantonio, A. D., B. N. Bimber, W. J. Neidermyer, Jr., R. K. Reeves, G. Alter, M. Altfeld, R. P. Johnson, M. Carrington, D. H. O'Connor, and D. T. Evans. 2011. KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. PLoS Pathog. 7: e1001316.
35. Older Aguilar, A. M., L. A. Guethlein, M. Hermes, L. Walter, and P. Parham. 2011. Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B. Immunogenetics 63: 577-585.
36. Committee on Care and Use of Laboratory Animals. 1985. Guide for the Care and Use of Laboratory Animals. National Institutes of Health, Department of Health and Human Services Publication 85-23, Washington, DC.
37. Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16: 111-120. (Pubitemid 11166431)
38. Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39: 783-791.
39. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328. (Pubitemid 19129961)
40. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361. (Pubitemid 41668738)
41. Pratt, B. F., D. H. O'Connor, B. A. Lafont, J. L. Mankowski, C. S. Fernandez, R. Triastuti, A. G. Brooks, S. J. Kent, and M. Z. Smith. 2006. MHC class I allele frequencies in pigtail macaques of diverse origin. Immunogenetics 58: 995-1001. (Pubitemid 44791232)
42. Reeves, R. K., J. Gillis, F. E. Wong, Y. Yu, M. Connole, and R. P. Johnson. 2010. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115: 4439-4446.
43. Webster, R. L., and R. P. Johnson. 2005. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115: 206-214. (Pubitemid 40733406)
44. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640. (Pubitemid 33043908)
45. Parham, P., L. Abi-Rached, L. Matevosyan, A. K. Moesta, P. J. Norman, A. M. Older Aguilar, and L. A. Guethlein. 2010. Primate-specific regulation of natural killer cells. J. Med. Primatol. 39: 194-212.
46. Parham, P., P. J. Norman, L. Abi-Rached, and L. A. Guethlein. 2011. Variable NK cell receptors exemplified by human KIR3DL1/S1. J. Immunol. 187: 11-19.
47. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185: 1523-1528. (Pubitemid 27187611)
48. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37. (Pubitemid 46033585)
49. Fadda, L., G. Borhis, P. Ahmed, K. Cheent, S. V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, F. H. Claas, et al. 2010. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 107: 10160-10165.
50. Fadda, L., G. M. O'Connor, S. Kumar, A. Piechocka-Trocha, C. M. Gardiner, M. Carrington, D. W. McVicar, and M. Altfeld. 2011. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J. Virol. 85: 5970-5974.
51. Fan, Q. R., E. O. Long, and D. C. Wiley. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2: 452-460. (Pubitemid 33706144)
52. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
53. Vivian, J. P., R. C. Duncan, R. Berry, G. M. O'Connor, H. H. Reid, T. Beddoe, S. Gras, P. M. Saunders, M. A. Olshina, J. M. Widjaja, et al. 2011. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479: 401-405.
54. Khakoo, S. I., R. Geller, S. Shin, J. A. Jenkins, and P. Parham. 2002. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 196: 911-921.
55. Fu, L., B. Hazes, and D. N. Burshtyn. 2011. The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site. J. Immunol. 187: 1816-1825.
56. Stewart-Jones, G. B., K. di Gleria, S. Kollnberger, A. J. McMichael, E. Y. Jones, and P. Bowness. 2005. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 35: 341-351. (Pubitemid 40331309)